EUPRAXIA PHARMACEUTICALS INC. (EPRX) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$0

Net Income/Loss (FY2025)

-$38.6M

Total Assets (FY2025)

$86.2M

Total Equity (FY2025)

$80.4M

Cash Flows from Operating Activities (FY2025)

-$28.6M

Source: EUPRAXIA PHARMACEUTICALS INC. 40-F filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.